Is Medigus Ltd. (MDGS) A Good Stock To Buy Now?
In this article we are going to use hedge fund sentiment as a tool and determine whether Medigus Ltd. (NASDAQ:MDGS) is a good investment right now.
Medigus Ltd. (MDGS)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | 0 | $0 | 0% | ||
| 2. | 0 | $0 | 0% | ||
| 3. | 0 | $0 | 0% |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 26,059 | $132,385 | 0.09% | |
| 2. | 19,632 | $99,730 | 0% | |
| 3. | 2,010 | $10,211 | 0% | |
| 4. | 405 | $2,060 | 0% | |
| 5. | 363 | $1,844 | 0% |
News See All
Hedge Funds Souring On Medigus Ltd. (MDGS)
In this article we will take a look at whether hedge funds think Medigus Ltd. (NASDAQ:MDGS) is a good investment right now.
Hedge Funds Have Never Been More Bullish On Medigus Ltd. (MDGS)
After several tireless days we have finished crunching the numbers from nearly 750 13F filings issued by the elite hedge funds and other investment firms that we track at Insider Monkey, which disclosed...
13G Filing: Sabby Capital and Medigus Ltd ADR (MDGS)
Sabby Healthcare Master Fund, Ltd | 0 | 7,336,461 | 0 | 7,336,461 | 7,336,461 | 4.85 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) CO CUSIP No. 58471G201 1.
13G Filing: Rima Senvest Management and Medigus Ltd. (MDGS)
The information required by Items 4(a) – (c) is set forth in Rows (5) – (11) of the cover page for each Reporting Person hereto and is incorporated herein by reference for each such Reporting Person...
13D Filing: Orbimed Israel Biofund Gp Limited Partnership and Medigus Ltd.
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because § 240.13d-1(e), 240.13d-1...
13G Filing: Sabby Capital and Medigus Ltd.
Sabby Healthcare Master Fund, Ltd | 0 | 3,044,391 | 0 | 3,044,391 | 3,044,391 | 6.21 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) CO CUSIP No. 58471G201 1.
Richard Mashaal's Latest Growth Candidate in Healthcare Is Medigus Ltd. (MDGS)
According to a recent 13G form filed with the Securities and Exchange Commission, Richard Mashaal's RIMA Senvest Management has disclosed an investment of about 64.96 million shares in the Israel-based...